Quarterly report pursuant to Section 13 or 15(d)

Schedule of Segment Information (Details)

v3.22.1
Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Consolidated net revenue $ 47,531 $ 15,271  
Consolidated cost of revenue 18,854 6,344  
Total Depreciation and amortization expense 1,176 348  
Operating and other expenses 11,591 7,522  
Total income from operations, after income taxes 12,494 1,057  
Total income from operations, before income taxes 15,910 1,057  
Income tax expense (3,416)  
Net income 12,494 1,057  
Total assets 99,665   $ 89,295
Diagnostic Services [Member]      
Segment Reporting Information [Line Items]      
Consolidated net revenue 44,913 12,737  
Consolidated cost of revenue 16,702 4,345  
Total Depreciation and amortization expense 576 345  
Total income from operations, after income taxes 20,026 2,839  
Total assets 51,823   51,150
Consumer Products [Member]      
Segment Reporting Information [Line Items]      
Consolidated net revenue 2,618 2,534  
Consolidated cost of revenue 2,152 1,999  
Total Depreciation and amortization expense 600 3  
Total income from operations, after income taxes (1,863) (35)  
Total assets 23,378   24,139
Unallocated Corporate [Member]      
Segment Reporting Information [Line Items]      
Total income from operations, after income taxes (2,253) $ (1,747)  
Total assets $ 24,464   $ 14,006